Top Markets
#1 OriginTrail OriginTrail +33.25%
#2 Siren Siren +31.25%
#3 MarsCoin MarsCoin +13.99%
#4 Pons Pons +13.41%
#5 Waves Waves +10.06%
#6 Cysic Cysic +8.41%
#7 Tutorial Tutorial +8.05%
#8 Synapse Synapse +7.41%
#9 TROLL TROLL +6.94%
#10 Cortex Cortex +6.55%
Coin of the day
OriginTrail OriginTrail
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Energenesis Biomedical CO.,LTD. Energenesis Biomedical CO.,LTD.

Energenesis Biomedical CO.,LTD.

6657
Classifica tra le azioni #22642
Energenesis Biomedical CO.,LTD., a firm established in 2012 and headquartered... Energenesis Biomedical CO.,LTD., a firm established in 2012 and headquartered in Taipei, Taiwan, is an active participant in the biomedicine sector. The company specializes in the development of a diverse range of medical solutions and research materials. Its primary pharmaceutical pipeline includes ENERGI-F703, which is currently undergoing Phase II clinical trials for the treatment of diabetic foot ulcers, and ENERGI-F701, a topical solution for addressing alopecia that is also in its second phase of clinical assessment. The comprehensive portfolio of therapeutic agents further encompasses: ENERGI-F711, formulated as a cream for burns. ENERGI-F702, designed to combat metabolic diseases. ENERGI-F704, targeting inflammatory bowel disease. ENERGI-F708, for the management of asthma. ENERGI-F705, aimed at controlling Parkinson's disease. ENERGI-F707, addressing mitochondrial deficiencies. ENERGI-F706, used to treat cachexia. ENERGI-F709, which serves as a vaccine adjuvant. ENERGI-F710, intended for the regulation of blood phosphate levels. Beyond its therapeutic developments, Energenesis Biomedical also provides a selection of scientific research products, including reagents for Western blotting, cell culture supplements, components for protein isolation and quantification, various laboratory dyes, and buffer solutions.
Prezzo delle azioni
$0.97305026
Ultima sincronizzazione: 2026-08-21
Capitalizzazione di mercato
$85.54M
Variazione (1 giorno)
1.16%
Variazione (1 anno)
-50.40%
Paese
TW
Scambia Energenesis Biomedical CO.,LTD. (6657)

Categoria

Healthcare
Utile per Energenesis Biomedical CO.,LTD. (6657)
Utile nel 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Energenesis Biomedical CO.,LTD., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, uguale a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Energenesis Biomedical CO.,LTD. dal 2026 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
Non abbastanza dati per le date fornite.
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH